Literature DB >> 11213930

The product of human cytomegalovirus UL73 is a new polymorphic structural glycoprotein (gpUL73).

P Dal Monte1, S Pignatelli, M Mach, M P Landini.   

Abstract

OBJECTIVES: This work focuses on human cytomegalovirus (HCMV) UL73, which encodes for a putative transmembrane glycoprotein that is highly conserved among herpesviruses. STUDY
DESIGN: pUL73 expression was analyzed both in transiently transfected and in HCMV-infected cells using a pUL73-specific antiserum by immunoblot and immunofluorescence. Sequencing analysis from several clinical isolates and laboratory-adapted strains was also performed.
RESULTS: pUL73 expressed in transiently transfected cells consists in a polypeptide of the expected size (15-18 kd) with cytoplasmic localization. In infected cells, pUL73 is expressed with true-late kinetics and localizes both in perinuclear granular formations and on the cell surface. A broad band (39-53 kd), sensitive to O-glycosidase digestion was detected in purified virus. In addition, sequence analysis showed that the N-terminal portion of pUL73 from clinical isolates is highly polymorphic.
CONCLUSIONS: UL73 encodes for a new structural glycoprotein (gpUL73) expressed on the cell surface of infected cells and highly polymorphic among clinical isolates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11213930

Source DB:  PubMed          Journal:  J Hum Virol        ISSN: 1090-9508


  7 in total

1.  Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.

Authors:  Ravit Arav-Boger; Sallie R Permar; Cody S Nelson; Diana Vera Cruz; Melody Su; Guanhua Xie; Nathan Vandergrift; Robert F Pass; Michael Forman; Marie Diener-West; Katia Koelle
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

2.  Complex formation by glycoproteins M and N of human cytomegalovirus: structural and functional aspects.

Authors:  Michael Mach; Barbara Kropff; Magdalena Kryzaniak; William Britt
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirus.

Authors:  S Spaderna; H Blessing; E Bogner; W Britt; M Mach
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.

Authors:  Masako Shimamura; Michael Mach; William J Britt
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.

Authors:  Suresh B Boppana; William J Britt
Journal:  Methods Mol Biol       Date:  2021

6.  Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women.

Authors:  Suchetha Murthy; Gary S Hayward; Sarah Wheelan; Michael S Forman; Jin-Hyun Ahn; Robert F Pass; Ravit Arav-Boger
Journal:  PLoS One       Date:  2011-01-10       Impact factor: 3.240

7.  Quantitative temporal viromics: an approach to investigate host-pathogen interaction.

Authors:  Michael P Weekes; Peter Tomasec; Edward L Huttlin; Ceri A Fielding; David Nusinow; Richard J Stanton; Eddie C Y Wang; Rebecca Aicheler; Isa Murrell; Gavin W G Wilkinson; Paul J Lehner; Steven P Gygi
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.